Legal Opinion
Antares Pharma, Inc. v. Medac Pharma Inc.
Court of Appeals for the Federal Circuit
Decided November 17, 2014No. 2014-1648PublishedCited by 19 opinions
1Opinion of the Court
DYK, Circuit Judge.
Plaintiff-Appellant Antares Pharma, Inc. (“Antares”) appeals from a decision of the United States District Court for the District of Delaware denying Antares’ motion for preliminary injunction. Antares seeks to enjoin alleged infringement of claims 31, 34, 35, and 37 of a reissue patent, RE44,846 (“the '846 patent”). Because we hold that these reissue claims are invalid for failure to comply with the “original patent” requirement of 35 U.S.C. § 251, we affirm.
BACK6ROUND
I
Antares is a developer of automatic injection devices used to self-administer pharmaceuticals. It is the…
2Cases cited28 opinions
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- Topliff v. TopliffSupreme Court of the United States · 1892
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Miller v. Brass Co.Supreme Court of the United States · 1882
- U. S. Industrial Chemicals, Inc. v. Carbide & Carbon Chemicals Corp.Supreme Court of the United States · 1942
23 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- Sleep Number Corporation v. Steven YoungCourt of Appeals for the Eighth Circuit · 2022
- SCA Hygiene Products Aktiebolag SCA Personal Care, Inc. v. First Quality Baby Products, LLCCourt of Appeals for the Federal Circuit · 2015
- Zimmer Surgical, Inc. v. Stryker Corp.District Court, D. Delaware · 2019
- Forum US, Inc. v. Flow Valve, LLCCourt of Appeals for the Federal Circuit · 2019
- Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.Court of Appeals for the Federal Circuit · 2022
14 more not listed; retrieve them via the Exa API.